Axa’s Inovalon Holdings, Inc. Class A Common Stock INOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-40,700
Closed -$1.08M 1380
2020
Q3
$1.08M Sell
40,700
-400
-1% -$9.36K ﹤0.01% 929
2020
Q2
$792K Hold
41,100
﹤0.01% 992
2020
Q1
$685K Buy
41,100
+16,300
+66% +$309K ﹤0.01% 918
2019
Q4
$467K Buy
+24,800
New +$415K ﹤0.01% 1006

Other funds holding INOV

Axa's INOV Position: Q4 2020 in Review

Axa sold out of Inovalon Holdings, Inc. Class A Common Stock (INOV) in Q4 2020, closing a stake of 40,700 shares — an estimated $1.08M sold.

Axa first reported a position in INOV in Q4 2019 and held it in 4 quarters. The position peaked at $1.08M in Q3 2020. 174 funds tracked by Wall St. Rank hold INOV as of Q4 2020.

  • Axa reported no remaining Inovalon Holdings, Inc. Class A Common Stock position as of Q4 2020 after selling out during the quarter.
  • Axa sold 40,700 Inovalon Holdings, Inc. Class A Common Stock shares in Q4 2020, an estimated $1.08M.
  • Axa first reported a position in Inovalon Holdings, Inc. Class A Common Stock in Q4 2019 and held it in 4 quarters.
  • Axa's Inovalon Holdings, Inc. Class A Common Stock position peaked at $1.08M in Q3 2020.
  • 174 funds tracked by Wall St. Rank held Inovalon Holdings, Inc. Class A Common Stock as of Q4 2020.

Based on Axa's 13F filing for Q4 2020, filed 12 Feb 2021.